Dr. Manubolu D. Devanand, MD

Dr. Devanand practices at Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System.

Dr. Devanand's NPI, 1659894889, was assigned on July 19, 2017. Dr. Devanand holds Illinois license 036153036.

Dr. Devanand's primary practice is Mount Sinai Hospital, at 15th Street at California, Chicago, IL 60608 in Cook County. The practice phone is (773) 542-2000. Dr. Devanand also practices at Mount Sinai Hospital Medical Center, 1500 S Fairfield Ave, Chicago, IL 60608.

Dr. Devanand's primary practice is Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System. Dr. Devanand is also affiliated with Holy Cross Hospital. The medical group on file is Sinai Medical Group. Dmand AI also links Dr. Devanand to 1 more hospital, 1 breast imaging center and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devanand practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Devanand's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Devanand is licensed in Illinois.

CMS data shows 54 Medicare services from Dr. Devanand across 2 procedure codes in 2024, all of them office visits, for 32 Medicare patients. Medicare paid $3,496 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 32 Medicare patients who saw Dr. Devanand in 2024. The largest group is 65 to 74, with 16 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 66% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Devanand's median patient age at 60, with 46% women.

In 2024, Dr. Devanand wrote 546 Medicare Part D claims for 51 patients. 77% of them were for generic drugs. CMS names the drug for 299 of them, across 17 drugs with 11 or more claims each, at $31,511 in total drug cost. In 2023, CMS named 202 claims across 11 drugs.

Dr. Devanand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Devanand as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Devanand from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Aucta Pharmaceuticals, Inc. paid the most, $12.